Jaiprakash Associates Ltd. - Research Center
532532 JPASSOCIAT Group (T) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Sales | 611.56 | 872.82 | 935.42 | 710.09 | 1,213.61 |
| Operating profit | 34.20 | 84.46 | 142.10 | 57.13 | 49.88 |
| Interest | 255.35 | 246.54 | 246.64 | 243.16 | 228.91 |
| Gross profit | -142.07 | -71.78 | -70.71 | -134.31 | -133.81 |
| EPS (Rs) | -1.13 | -4.40 | -2.75 | -1.97 | -0.85 |
Quarterly
results in details
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Other income | 79.08 | 90.30 | 33.83 | 51.72 | 45.22 |
| Stock adjustment | -5.97 | 0.75 | 6.89 | 3.57 | 0.76 |
| Raw material | 145.83 | 171.45 | 225.34 | 184.49 | 190.03 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 81.10 | 80.66 | 89.85 | 77.60 | 77.63 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 356.40 | 535.50 | 471.24 | 387.30 | 895.31 |
| Provisions made | - | - | - | - | - |
| Depreciation | 47.65 | 53.90 | 58.16 | 58.77 | 60.30 |
| Taxation | 0.91 | 2.13 | 5.06 | 9.62 | 1.79 |
| Net profit / loss | -276.62 | -1,080.34 | -674.42 | -482.41 | -207.55 |
| Extra ordinary item | -85.99 | -952.53 | -540.49 | -279.71 | -11.65 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 490.92 | 490.92 | 490.92 | 490.92 | 490.92 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 5.59 | 9.68 | 15.19 | 8.05 | 4.11 |
| GPM (%) | -20.57 | -7.45 | -7.30 | -17.63 | -10.63 |
| NPM (%) | -40.05 | -112.17 | -69.58 | -63.32 | -16.49 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis